Literature DB >> 6694263

Development of antibody to measles virus polypeptides during complicated and uncomplicated measles virus infections.

M Graves, D E Griffin, R T Johnson, R L Hirsch, I L de Soriano, S Roedenbeck, A Vaisberg.   

Abstract

Immune precipitation of 181 sera from 152 patients with natural measles was studied to determine the temporal course and frequency of antibody responses to nucleocapsid, fusion, hemagglutinin, and matrix proteins of measles virus. Large amounts of antibody to nucleocapsid protein developed in all patients by day one of the rash. Antibody to hemagglutinin and fusion proteins developed in all patients over the next 3 weeks, the former to high levels and the latter to low levels. Antibody to matrix protein developed to very low levels and was detectable in only 41% of the patients; this poor response to matrix protein was not correlated with the age of the patient or the acute neurological complications of measles.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6694263      PMCID: PMC255480     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Studies on the development of complement fixing antibodies in measles patients. Observations during a measles epidemic in Greenland.

Authors:  V BECH
Journal:  J Immunol       Date:  1959-09       Impact factor: 5.422

2.  Abnormal levels of antibodies to measles-virus proteins in patient with mental retardation and seizures 24 years after measles encephalitis.

Authors:  W W Hall; V Sahgal; D H Harter; P W Choppin
Journal:  Lancet       Date:  1979-11-03       Impact factor: 79.321

3.  Evidence for lack of synthesis of the M polypeptide of measles virus in brain cells in subacute sclerosing panencephalitis.

Authors:  W W Hall; P W Choppin
Journal:  Virology       Date:  1979-12       Impact factor: 3.616

4.  Antibodies to the structural polypeptides of measles virus following acute infection and in SSPE.

Authors:  A Trudgett; W J Bellini; E S Mingioli; D E McFarlin
Journal:  Clin Exp Immunol       Date:  1980-03       Impact factor: 4.330

5.  Measles and subacute sclerosing panencephalitis virus proteins: lack of antibodies to the M protein in patients with subacute sclerosing panencephalitis.

Authors:  W W Hall; R A Lamb; P W Choppin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

6.  Immunological evidence for the synthesis of all canine distemper virus polypeptides in chronic neurological diseases in dogs. Chronic distemper and old dog encephalitis differ from SSPE in man.

Authors:  W W Hall; D T Imagawa; P W Choppin
Journal:  Virology       Date:  1979-10-15       Impact factor: 3.616

7.  Immune response in subacute sclerosing panencephalitis: reduced antibody response to the matrix protein of measles virus.

Authors:  S L Wechsler; H L Weiner; B N Fields
Journal:  J Immunol       Date:  1979-08       Impact factor: 5.422

8.  Risk factors in subacute sclerosing panencephalitis: a case-control study.

Authors:  N A Halsey; J F Modlin; J T Jabbour; L Dubey; D L Eddins; D D Ludwig
Journal:  Am J Epidemiol       Date:  1980-04       Impact factor: 4.897

9.  Antigenic relationships between measles and canine distemper viruses: comparison of immune response in animals and humans to individual virus-specific polypeptides.

Authors:  J R Stephenson; V ter Meulen
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

10.  Appearance and persistence of antibodies against different virus components after regular measles infections.

Authors:  E Norrby; Y Gollmar
Journal:  Infect Immun       Date:  1972-09       Impact factor: 3.441

View more
  22 in total

1.  Measles virus (MV) nucleoprotein binds to a novel cell surface receptor distinct from FcgammaRII via its C-terminal domain: role in MV-induced immunosuppression.

Authors:  David Laine; Marie-Claude Trescol-Biémont; Sonia Longhi; Geneviève Libeau; Julien C Marie; Pierre-Olivier Vidalain; Olga Azocar; Adama Diallo; Bruno Canard; Chantal Rabourdin-Combe; Hélène Valentin
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

2.  Insights into the regulatory mechanism controlling the inhibition of vaccine-induced seroconversion by maternal antibodies.

Authors:  Dhohyung Kim; Devra Huey; Michael Oglesbee; Stefan Niewiesk
Journal:  Blood       Date:  2011-02-28       Impact factor: 22.113

3.  Envelope-chimeric entry-targeted measles virus escapes neutralization and achieves oncolysis.

Authors:  Tanner S Miest; Koon-Chu Yaiw; Marie Frenzke; Johanna Lampe; Andrew W Hudacek; Christoph Springfeld; Veronika von Messling; Guy Ungerechts; Roberto Cattaneo
Journal:  Mol Ther       Date:  2011-05-24       Impact factor: 11.454

4.  Recombinant antibodies generated from both clonal and less abundant plasma cell immunoglobulin G sequences in subacute sclerosing panencephalitis brain are directed against measles virus.

Authors:  Mark P Burgoon; Yupanqui A Caldas; Kathryne M Keays; Xiaoli Yu; Donald H Gilden; Gregory P Owens
Journal:  J Neurovirol       Date:  2006-10       Impact factor: 2.643

Review 5.  Emerging diseases: measles.

Authors:  Martin O Ota; William J Moss; Diane E Griffin
Journal:  J Neurovirol       Date:  2005-10       Impact factor: 2.643

6.  Antibody response to respiratory syncytial virus structural proteins in children with acute respiratory syncytial virus infection.

Authors:  R Vainionpää; O Meurman; H Sarkkinen
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

7.  Characterization of immunodominant linear B-cell epitopes on the carboxy terminus of the rinderpest virus nucleocapsid protein.

Authors:  Kang-Seuk Choi; Jin-Ju Nah; Young-Joon Ko; Shien-Young Kang; Kyoung-Jin Yoon; Yi-Seok Joo
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

8.  Comparison of the immune responses induced by chimeric alphavirus-vectored and formalin-inactivated alum-precipitated measles vaccines in mice.

Authors:  M Jeff Bergen; Chien-Hsiung Pan; Catherine E Greer; Harold S Legg; John M Polo; Diane E Griffin
Journal:  PLoS One       Date:  2010-04-22       Impact factor: 3.240

9.  Cell surface delivery of the measles virus nucleoprotein: a viral strategy to induce immunosuppression.

Authors:  Julien C Marie; Frédéric Saltel; Jean-Michel Escola; Pierre Jurdic; T Fabian Wild; Branka Horvat
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

10.  Baculovirus expression of the nucleoprotein gene of measles virus and utility of the recombinant protein in diagnostic enzyme immunoassays.

Authors:  K B Hummel; D D Erdman; J Heath; W J Bellini
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.